UK firms move from AI experimentation to measurable results as the Project Economy matures
Nearly half of UK organisations report productivity or cost improvements from AI,…
Statement from OCI Global
AMSTERDAM, April 17, 2026 /PRNewswire/ -- OCI Global N.V. ("OCI" or the…
Xinhua Silk Road: Ningbo and China’s shift from making things to making them smarter
BEIJING, April 17, 2026 /PRNewswire/ -- Along China's eastern seaboard, the Ningbo-Zhoushan Port…
Sigenergy Successfully Listed on HKEX with Strong Backing from Top-Tier Global Investors
HONG KONG, April 16, 2026 /PRNewswire/ -- Sigenergy Technology Co., Ltd. ("Sigenergy",…
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS…
Risen Energy Secures 1.2GW HJT Module Order from China Huaneng Group, Demonstrating Industry Leadership
NINGBO, China, April 15, 2026 /PRNewswire/ -- Recently, Risen Energy achieved a…
A Look at the Highlights from Phase 1 of the 139th Canton Fair
GUANGZHOU, China, April 14, 2026 /PRNewswire/ -- Focusing on Advanced Manufacturing, Phase 1…
Breaking the Bottleneck in Medical Imaging Core Components: VITAL MedTech Unveils Its Vertical Integration Solution from Materials to Medical Systems at CMEF 2026
SHANGHAI, April 13, 2026 /PRNewswire/ -- At CMEF 2026, VITAL MedTech, the…
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION
April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent…
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
April 10, 2026 17:02 ET | Source: Replimune, Inc. WOBURN, Mass., April…


